İHSAN ÇETİN

Prof. Dr. İHSAN ÇETİN

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2023 in Universa Medicina
Verified
Journal Article
Open access
PDF file
EGEsin Gullu
Esin Gullu
AEAbdulsamet Efdal
Abdulsamet Efdal
AGAbdullah Gullu
Abdullah Gullu
İÇİHSAN ÇETİN
İHSAN ÇETİN
Background Artificial turf fields are widely used as an alternative to natural grass in many areas such as parks, playgrounds, and playing fields. In this study, we aimed to evaluate the toxicological effects of the chemicals contained in the fields consisting of artificial turf and crumb rubber on the blood metal levels in field hockey players. MethodsA cross-sectional study was conducted involving 28 apparently healthy men aged 20-25 years who participated in this study voluntarily. They consisted of 17 field hockey athletes [athlete group (AG)] and 11 sedentary males [control group (CG)]. Before and after the 7-day tournament, blood samples were taken from AG and CG to measure mercury, arsenic, aluminum, lead, zinc, magnesium and iron levels. An independent t-test was used to analyze the data. ResultsIn comparisons between CG and AG, the magnesium level of AG before the tournament was higher, while the iron and mercury levels were significantly lower (p<0.05). In intragroup comparisons, a significant increase was observed in the post-tournament magnesium and iron variables in the AG group (p<0.05). In post-tournament intergroup comparisons, increases in the Mg and decreases in the Hg variables of AG were significant (p<0.05). ConclusionIt is thought that as a result of the tournament on fields with synthetic grass surfaces, the male field hockey players in the 20-25 age group were toxicologically not affected by the harmful heavy metals present in these fields, because the Hg, As, Pb, Zn, Al, Fe, and Mg levels are within the international reference ranges.

23 June 2026 in Brain Sciences
Verified
Journal Article
Open access
PDF file
AAAli Osman ARSLAN
Ali Osman ARSLAN
İÇİHSAN ÇETİN
İHSAN ÇETİN
ÖYÖzgür Mehmet Yis
Özgür Mehmet Yis
SUSevdenur Uzun
Sevdenur Uzun
GAGuven AKCAY
Guven AKCAY
Background: Schizophrenia is a chronic neuropsychiatric disorder characterized by cognitive impairment, behavioral abnormalities, neuroinflammation, and oxidative stress. Increasing evidence suggests that dysregulated inflammatory cytokines and impaired antioxidant defenses contribute to schizophrenia pathophysiology. This study investigated the neuroprotective and anti-inflammatory effects of Gallic Acid (GA) in a ketamine-induced experimental schizophrenia model. Methods: Thirty male Balb/C mice were randomly divided into control, ketamine, and ketamine + GA groups. Schizophrenia was induced with ketamine (25 mg/kg/day) for 7 days, while the treatment group additionally received GA (60 mg/kg/day) for another 7 days. Behavioral tests, including open field, novel object recognition, and tail suspension tests, were performed to evaluate locomotor activity, cognition, and depressive-like behavior. Tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), interleukin-18 (IL-18), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), total antioxidant status (TAS), and total oxidant status (TOS) levels were analyzed in hippocampal and prefrontal cortex tissues to assess inflammatory and oxidative stress-related alterations. Results: Ketamine induced schizophrenia-like behaviors, including hyperlocomotion, memory impairment, and increased immobility. These behavioral alterations were accompanied by significantly elevated TNF-α, IL-1β, IL-18, and TOS levels, alongside reduced SOD, CAT, GSH-Px, and TAS levels in the hippocampus and prefrontal cortex. GA treatment ameliorated behavioral impairments, restored antioxidant enzymes, increased TAS levels, and reduced pro-inflammatory cytokines and TOS in these brain regions. Conclusions: GA exerted neuroprotective effects in the ketamine-induced schizophrenia model by reducing oxidative stress, neuroinflammation, and behavioral deficits. These findings suggest that Gallic Acid may serve as a promising therapeutic candidate for schizophrenia through modulation of inflammatory and oxidative stress pathways.